Otida is a HealthTech startup founded in 2021 in Egypt. The company aims to revolutionize diabetes care by offering an innovative and efficient care model for diabetic patients. Their focus is on reversing Type II diabetes and sustainably managing Type I diabetes through digital therapeutics, wearables, and continuous remote monitoring. This approach aligns with the growing trend of leveraging technology to improve healthcare outcomes.
Recently, Otida secured a $340.00K Pre Seed Round investment on 28 March 2022. The investment was led by a consortium of investors including LoftyInc Alpha Fund, Jedar Capital, Flat6Labs Egypt, Ali Rampurwala, Oqal, UI Investments, and Afropreneurs. This financial backing provides the company with the resources necessary to further develop and scale its innovative diabetes care solutions.
With its strategic focus on leveraging technology for healthcare and a solid backing from a diverse group of investors, Otida appears well-positioned to make a meaningful impact in the Health Care, Health and Wellness, and Sports industries.